StockWatch
·

Venmax Drugs And Pharmaceuticals Ltd Q2 FY26 Results

VENMAXQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue1.328.9%671.0%
Total Income1.328.9%671.0%
Expenditure1.278.6%167.5%
PBT0.0520.6%114.8%
Net Profit0.0235.0%108.0%
OPM3.54%0.36pp
NPM1.84%1.25pp
EPS0.0528.6%108.6%
View full financials

Informational and educational content only. Not investment advice.